The FDA announced revocation of the Emergency Use Authorization for the xMAP MultiFLEX Zika RNA Assay at the request of the manufacturer, Luminex Corporation, following Luminex’s decision to discontinue the product. Read the FDA notice and Luminex request letter.
-
- Overview
- Developmental path of the infection preventionist
- Infection preventionist (IP) competency model
- APIC Fellows Program
- Implementation guides
- Practice resources
- Scientific guidelines
- Research
- Emergency preparedness
- AJIC
- International Infection Prevention Week
- MegaSurvey
- Practice Guidance Committee Activities
-
- Overview
- CIC Certification
- Annual Conference 2020
- Face-to-Face Learning
- Online Learning
- NEW! APIC's 2019 Virtual Conference
- NEW! Bundled Learning Options
- Group Training
- EPI® in Long-Term Care Certificate Series
- APIC/SHEA Joint Leadership Development Course
- Applied Learning Conference
- Accreditation & Contact Hours